Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
8.81
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
9.08
+0.27 (3.06%)
After-hours: Dec 5, 2025, 7:01 PM EST
Corvus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 2.87 | 8.74 | 12.62 | 13.16 | 63.46 | 16.46 | Upgrade
|
| Short-Term Investments | 62.82 | 43.22 | 14.53 | 29.14 | 5.99 | 27.8 | Upgrade
|
| Cash & Short-Term Investments | 65.69 | 51.96 | 27.15 | 42.3 | 69.45 | 44.26 | Upgrade
|
| Cash Growth | 57.71% | 91.40% | -35.82% | -39.09% | 56.92% | -43.24% | Upgrade
|
| Accounts Receivable | 0.03 | 0.08 | 0.03 | 0.59 | 0.51 | - | Upgrade
|
| Other Receivables | 0.31 | 0.14 | 0.04 | 0.05 | 0.03 | 0.09 | Upgrade
|
| Receivables | 0.35 | 0.22 | 0.06 | 0.63 | 0.54 | 0.09 | Upgrade
|
| Prepaid Expenses | 0.22 | 0.47 | 0.38 | 0.43 | 0.45 | 0.4 | Upgrade
|
| Other Current Assets | 0.69 | 1.76 | 0.37 | 0.29 | 0.87 | 0.59 | Upgrade
|
| Total Current Assets | 66.94 | 54.41 | 27.96 | 43.66 | 71.31 | 45.34 | Upgrade
|
| Property, Plant & Equipment | 1.15 | 1.33 | 1.39 | 2.57 | 3.64 | 2.55 | Upgrade
|
| Long-Term Investments | 11.53 | 12.54 | 16.12 | 21.88 | 34.27 | 37.23 | Upgrade
|
| Other Long-Term Assets | 0.85 | 0.63 | 0.09 | 0.13 | 0.24 | 0.41 | Upgrade
|
| Total Assets | 80.47 | 68.91 | 45.55 | 68.24 | 109.46 | 85.53 | Upgrade
|
| Accounts Payable | 1.97 | 2.58 | 1.53 | 1.98 | 1.57 | 3.47 | Upgrade
|
| Accrued Expenses | 5.16 | 3.44 | 3.73 | 7.39 | 6.96 | 7.42 | Upgrade
|
| Current Portion of Leases | 0.38 | 0.19 | 1.37 | 1.23 | 1.05 | 1.08 | Upgrade
|
| Other Current Liabilities | 0.57 | 29.2 | 0.25 | 0.16 | 0.12 | 0.18 | Upgrade
|
| Total Current Liabilities | 8.07 | 35.4 | 6.87 | 10.75 | 9.69 | 12.15 | Upgrade
|
| Long-Term Leases | 0.63 | 0.94 | - | 1.37 | 2.6 | 1.23 | Upgrade
|
| Total Liabilities | 8.71 | 36.34 | 6.87 | 12.13 | 12.29 | 13.38 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 472.79 | 430.86 | 374.36 | 364.36 | 361.67 | 295.28 | Upgrade
|
| Retained Earnings | -399.97 | -397.01 | -334.72 | -307.69 | -266.38 | -223.14 | Upgrade
|
| Comprehensive Income & Other | -1.06 | -1.29 | -0.97 | -0.56 | 1.87 | 0 | Upgrade
|
| Total Common Equity | 71.77 | 32.57 | 38.68 | 56.12 | 97.16 | 72.15 | Upgrade
|
| Shareholders' Equity | 71.77 | 32.57 | 38.68 | 56.12 | 97.16 | 72.15 | Upgrade
|
| Total Liabilities & Equity | 80.47 | 68.91 | 45.55 | 68.24 | 109.46 | 85.53 | Upgrade
|
| Total Debt | 1.01 | 1.12 | 1.37 | 2.6 | 3.65 | 2.31 | Upgrade
|
| Net Cash (Debt) | 64.68 | 50.84 | 25.78 | 39.7 | 65.8 | 41.95 | Upgrade
|
| Net Cash Growth | 56.62% | 97.25% | -35.08% | -39.67% | 56.87% | -43.91% | Upgrade
|
| Net Cash Per Share | 0.86 | 0.83 | 0.54 | 0.85 | 1.57 | 1.42 | Upgrade
|
| Filing Date Shares Outstanding | 74.68 | 68.14 | 49.04 | 46.57 | 46.55 | 38.31 | Upgrade
|
| Total Common Shares Outstanding | 74.68 | 67.9 | 49.04 | 46.55 | 46.55 | 28.37 | Upgrade
|
| Working Capital | 58.87 | 19.01 | 21.09 | 32.91 | 61.62 | 33.19 | Upgrade
|
| Book Value Per Share | 0.96 | 0.48 | 0.79 | 1.21 | 2.09 | 2.54 | Upgrade
|
| Tangible Book Value | 71.77 | 32.57 | 38.68 | 56.12 | 97.16 | 72.15 | Upgrade
|
| Tangible Book Value Per Share | 0.96 | 0.48 | 0.79 | 1.21 | 2.09 | 2.54 | Upgrade
|
| Machinery | 2.81 | 2.69 | 2.85 | 2.82 | 2.62 | 2.61 | Upgrade
|
| Leasehold Improvements | 0.03 | 2.08 | 2.08 | 2.08 | 2.08 | 2.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.